The combination of PD-1 and PD-L1 induces apoptosis, depletion, and hypofunction in T cells, which in turn inhibits the activation, proliferation, and antitumor activity of CD8+ T cells specific to tumor antigen (79, 89–94). The gene discussed is CD274; the disease is neoplasm.